Peptide News Digest

#Uspto

1 story

Regulatory · View digest

U.S. Patent and Trademark Office Seeks Ideas for a Counterfeit-Medicine Campaign That Could Recruit Celebrities and Influencers

The USPTO posted a request for information on a nationwide public awareness campaign about counterfeit drugs and medical devices, with videos, a microsite, social media, and plans to "identify and pitch key individuals (influencers, celebrities, journalists)," Newsweek reported. The notice is market research, not a contract, and industry responses are due November 16. Newsweek's report cited past U.S. seizures of counterfeit Ozempic and of fake semaglutide, tirzepatide, and retatrutide injections.